Tumor antigenicity and approaches to tumor immunotherapy. An outline.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000235:genetics / Q000494:pharmacology; D000912:Antibodies, Neoplasm / Q000276:immunology; D000917:Antibody Formation; D000921:Antibody-Producing Cells / Q000145:classification / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology*; D002273:Carcinogens / Q000494:pharmacology; D003429:Cross Reactions; D003602:Cytotoxicity, Immunologic; D005802:Genes, MHC Class II; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007167:Immunotherapy / Q000639:trends*; D008214:Lymphocytes / Q000145:classification / Q000276:immunology; D009369:Neoplasms / Q000209:etiology / Q000382:microbiology / Q000628:therapy*; D009858:Oncogenic Viruses / Q000302:isolation & purification
D000276:Adjuvants, Immunologic; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D002273:Carcinogens